Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 53.05
-0.13 (-0.24%)
May 28, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 31.58 billion as of May 28, 2026. Its market cap has increased by 5.84% in one year.
Market Cap
31.58B
Enterprise Value
28.16B
Revenue
3.95B
Ranking
n/a
PE Ratio
30.62
Stock Price
53.05
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 31.58B, a decrease of -13.66%. That is a compound annual growth rate of -2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 31.65B | -21.87% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iRay Group | 38.86B |
| Andon Health | 38.32B |
| Imeik Technology Development | 30.72B |
| Intco Medical Technology | 29.61B |
| Zhende Medical | 22.96B |
| Jiangsu Hualan New Pharmaceutical Material | 21.12B |
| Winner Medical | 17.46B |
| Qingdao NovelBeam Technology | 16.51B |